EN
登录

Solvias将在三角研究园建立生物制品和细胞基因治疗测试中心

Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park

BioSpace 等信源发布 2024-05-06 21:45

可切换为仅中文


Global provider continues to expand analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases

全球供应商继续扩大生命科学公司的分析服务能力,为癌症和罕见疾病开发先进的治疗方法

KAISERAUGST, Switzerland, May 6, 2024 /PRNewswire/ -- Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development..

瑞士凯瑟劳格斯特(KAISERAUGST),2024年5月6日/PRNewswire/--索尔维亚(Solvias)今天宣布,它正在扩大其实验室测试中心的全球网络,并在北卡罗来纳州三角研究公园(Research Triangle Park)建立了一个新的生物技术网站。这是该公司最新的一项投资,旨在扩大其分析测试服务,以支持生命科学组织,同时越来越多的细胞和基因疗法(CGT)以及正在使用和开发的生物制剂。。

The 50,000-square-foot facility, expected to be completed in 2025 and bring 170+ jobs to the Raleigh-Durham area, will serve as Solvias' North American hub for large molecule analytical services. It will offer critical cell-based potency assays, advanced Next-Gen Sequencing (NGS) capabilities, and related testing services supporting multiple biologic modalities.

这座占地5万平方英尺的设施预计将于2025年完工,为罗利-达勒姆地区带来170多个就业岗位,将成为索尔维亚的北美大分子分析服务中心。它将提供关键的基于细胞的效力测定,先进的下一代测序(NGS)功能以及支持多种生物学模式的相关测试服务。

From the outset, the new testing center will support characterization and release testing of CGT and other advanced therapies, including Adeno-Associated virus (AAV) gene therapies, mRNA therapies and antibody drug conjugates..

从一开始,新的测试中心将支持CGT和其他先进疗法的表征和发布测试,包括腺相关病毒(AAV)基因疗法,mRNA疗法和抗体-药物偶联物。。

Noting that the global CGT and advanced biologics market is expected to maintain a double-digit annual growth rate over the next ten years, Archie Cullen, CEO of Solvias, said: 'Our new center strongly complements our biologics and CGT sites in Europe and expands our world-class testing capabilities in the U.S.

Solvias首席执行官阿尔奇·卡伦(ArchieCullen)指出,预计未来十年全球CGT和先进生物制品市场将保持两位数的年增长率,他说:“我们的新中心有力地补充了我们在欧洲的生物制品和CGT网站,并扩大了我们在美国的世界级测试能力。

Our team is thrilled to bring our newest center of excellence to Research Triangle Park, a leading research and development center and burgeoning hub for the life science industry. We will continue to invest in expanding our capabilities to support our customers with their critical work of developing and maintaining life-changing therapies.'.

我们的团队很高兴将我们最新的卓越中心带到三角研究园,三角研究园是领先的研发中心,也是生命科学行业的新兴中心。我们将继续投资扩大我们的能力,以支持我们的客户开发和维护改变生命的疗法的关键工作。”。

Solvias' new facility expands its global footprint to six centers of excellence. It is the company's second site in the U.S., where it supports life science organizations with analytical testing. The new center will feature state-of-the-art analytical instrumentation, laboratory automation technology and integrated digital management systems..

索维亚的新设施将其全球足迹扩展到六个卓越中心。它是该公司在美国的第二个网站,为生命科学组织提供分析测试支持。新中心将配备最先进的分析仪器、实验室自动化技术和集成数字管理系统。。

About Solvias

关于索维亚

Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life science industry. Its team of scientists combine years of experience with regulatory understanding across small molecules, biologics, and cell and gene therapies. The company offers comprehensive solutions from raw materials to drug products to final release testing, as well as API development and manufacturing for small molecules.

Solvias是一家为生命科学行业提供化学、制造和控制(CMC)分析的全球供应商。它的科学家团队将多年的经验与对小分子,生物制剂以及细胞和基因疗法的监管理解相结合。该公司提供从原材料到药品到最终释放测试的全面解决方案,以及针对小分子的API开发和制造。

Headquartered near Basel, Switzerland, Solvias operates five global centers of excellence to the highest standards and in accordance with ISO, GMP, GLP and FDA regulations. For more information, visit solvias.com..

Solvias总部位于瑞士巴塞尔附近,根据ISO、GMP、GLP和FDA法规,按照最高标准运营五个全球卓越中心。有关更多信息,请访问solvias.com。。

View original content to download multimedia:https://www.prnewswire.com/news-releases/solvias-to-build-biologics-and-cell--gene-therapy-testing-center-in-research-triangle-park-302135596.html

查看原始内容以下载多媒体:https://www.prnewswire.com/news-releases/solvias-to-build-biologics-and-cell--gene-therapy-testing-center-in-research-triangle-park-302135596.html

SOURCE Solvias

Solvias喷泉